Catalyst Wire Dossier Catalyst Wire Dossier

Endoscopic Intestinal Re-Cellularization Therapy

· Endogenex, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Endoscopic Intestinal Re-Cellularization Therapy, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes [NA]

See pricing